5-[4-(4-chlorobenzoyl)piperazin-1-yl]-8-nitroquinoline
Structure Info
- Chemspace ID
- CSSS00020618127 (In-Stock Screening Compounds)
- CAS
- 115687-05-3
- MFCD
- MFCD02039810
- IUPAC Name
- 5-[4-(4-chlorobenzoyl)piperazin-1-yl]-8-nitroquinoline
- Mol formula
- C20H17ClN4O3
- Mol weight
- 397 Da
- Catalog Number(s)
- 115687-05-3, 272015, 6133799, A1328377, AA000GOL, AA21521, ACM115687053, ADB3934705001, AG000GRD, AI21521, AP115687053, AR000HGD, B7209, B820015, BD01274752, BS-52744, BUP08079, CSC020618127, CSCR01409173097, E77878, F861571, HY-107660, IN2073, JH616621, LAN-B51294, LN00902038, M27605, M338713, OR1024236, OSSK_526587, QEA68705, STK148613, T22595, TX000HX1, Y1215610, Y227307, Y4288843, Z57462121, s_27____19498780____116268
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.71
- Heavy atoms count
- 28
- Rotatable bond count
- 3
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.2
- Polar surface area (Å)
- 80
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSS00020618127
Items Overall 13 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 95.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 10 mg | 148.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 25 mg | 252.00 | |
Description: Names: SIRT2-IN-8; Product Description: SIRT2-IN-8 is a potent SIRT2 inhibitor. SIRT2-IN-8 can be used for Huntington’s and Parkinson’s diseases research; Target: Sirtuin; CAS: 115687-05-3 | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 95.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 148.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 252.00 | |
Description: Names: SIRT2-IN-8; Product Description: SIRT2-IN-8 is a potent SIRT2 inhibitor. SIRT2-IN-8 can be used for Huntington’s and Parkinson’s diseases research; Target: Sirtuin; CAS: 115687-05-3 | ||||||
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 2 mg | 41.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 mg | 65.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 10 mg | 103.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 25 mg | 176.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 50 mg | 251.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 100 mg | 363.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 99 | 200 mg | 483.00 | |
Description: B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease; CAS: 115687-05-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire